These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 2211028)

  • 1. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit.
    Ohdo S; Zhu J; Lee VH
    Life Sci; 1992; 51(26):2025-31. PubMed ID: 1474859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K; Urtti A
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application site dependent ocular absorption of timolol.
    Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
    J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.
    Chang SC; Lee VH
    J Ocul Pharmacol; 1987; 3(2):159-69. PubMed ID: 3503911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.
    Chang SC; Chien DS; Bundgaard H; Lee VH
    Exp Eye Res; 1988 Jan; 46(1):59-69. PubMed ID: 3342834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
    Lee VH; Yamahara H; Gurny R; Sintzel MB; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder SK
    J Ocul Pharmacol Ther; 1996; 12(2):103-13. PubMed ID: 8773926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular drug interactions involving topically applied timolol in the pigmented rabbit.
    Luo AM; Sasaki H; Lee VH
    Curr Eye Res; 1991 Mar; 10(3):231-40. PubMed ID: 2044391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol.
    Urtti A; Kyyrönen K
    J Ocul Pharmacol; 1989; 5(2):127-32. PubMed ID: 2754297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
    Acheampong AA; Breau A; Shackleton M; Luo W; Lam S; Tang-Liu DD
    J Ocul Pharmacol Ther; 1995; 11(4):489-502. PubMed ID: 8574812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of topical ocular phenylephrine HCl.
    Antoine ME; Edelhauser HF; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1984 Jan; 25(1):48-54. PubMed ID: 6698730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsions as topical delivery vehicles: ocular administration of timolol.
    Gasco MR; Gallarate M; Trotta M; Bauchiero L; Gremmo E; Chiappero O
    J Pharm Biomed Anal; 1989; 7(4):433-9. PubMed ID: 2490750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.
    Arnold JJ; Hansen MS; Gorman GS; Inoue T; Rao V; Spellen S; Hunsinger RN; Chapleau CA; Pozzo-Miller L; Stamer WD; Challa P
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1118-26. PubMed ID: 23307957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic differences between ocular inserts and eyedrops.
    Friedrich SW; Saville BA; Cheng YL; Rootman DS
    J Ocul Pharmacol Ther; 1996; 12(1):5-18. PubMed ID: 8925396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits.
    Sasaki H; Ichikawa M; Kawakami S; Yamamura K; Mukai T; Nishida K; Nakamura J
    J Pharm Pharmacol; 1997 Feb; 49(2):140-4. PubMed ID: 9055184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.